Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›BIO RAD HbA1C

U.S. Department Of Veterans Affairs·Ohio

BIO RAD HbA1C

Closes 12/12/2025$10k – $100kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The intent of this solicitation is to sole source the BIO RAD HbA1C. The Department of Veterans Affairs is seeking to acquire this product, but the document does not provide further details about the scope of work or the requirements for the solicitation. • The solicitation is for a specific product, BIO RAD HbA1C. • The NAICS code for this solicitation is 325413. • The contact person for this solicitation is Rachelle Hamer. • The solicitation is a sole source solicitation, meaning that the Department of Veterans Affairs intends to award the contract to a single vendor.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Rachelle Hamer

[email protected]

(216) 447-8300

Key dates

Opened
12/9/2025
Closes
12/12/2025

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
36C25026Q0161

Budget estimate

$10,000 – $100,000

The budget for this solicitation is difficult to estimate because the document does not provide information about the quantity of the product being acquired or the price per unit. However, based on the fact that it is a sole source solicitation for a specific product, the budget could be relatively low, possibly in the range of $10,000 to $100,000. The actual budget will depend on the specifics of the contract, including the quantity of the product and the price per unit.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 60%

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

59% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

59% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

59% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center

Closes 10/31/2026Opened 9/18/2025

U.S. Department Of Veterans Affairs·Texas

59% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

59% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. Department Of Defense·Maryland

58% match

Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)

Closes 11/16/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

58% match

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Closes 3/10/2027Opened 9/18/2025

U.S. National Institutes of Health·United States of America

58% match

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Closes 1/6/2028Opened 12/22/2021

U.S. National Institutes of Health·United States of America

58% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

58% match

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Closes 2/9/2027Opened 8/20/2026

U.S. Department Of Veterans Affairs·Illinois

58% match

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

58% match

Limited Competition: Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program

Closes 1/26/2028Opened 5/26/2026

U.S. National Institutes of Health·United States of America

58% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Closes 2/3/2027Opened 4/1/2024

U.S. National Institutes of Health·United States of America

58% match

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Closes 10/12/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

58% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

57% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. Department Of Defense·United States of America

57% match

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1

Closes 7/31/2028Opened 8/11/2023

U.S. National Institutes of Health·United States of America

57% match

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

57% match

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Closes 3/9/2027Opened 8/4/2026

U.S. National Institutes of Health·United States of America

57% match

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

Closes 8/21/2028Opened 7/17/2025

U.S. National Institutes of Health·United States of America

57% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers

Closes 10/31/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

57% match

Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

Closes 1/29/2029Opened 9/2/2025

U.S. Department Of Veterans Affairs·California

57% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026

U.S. Department Of Health And Human Services·Maryland

56% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024